ENTITY
Sawai Pharmaceutical

Sawai Pharmaceutical (4555 JP)

9
Analysis
Health Care • Japan
SAWAI PHARMACEUTICAL CO., LTD. develops, manufactures, wholesales prescription and generic drugs such as antibiotics, anticancer agents, and circulatory agents.
more
•29 Apr 2021 17:41

JPX-Nikkei 400 Rebalance 2021: Pre-Event Basket Adjustments for April-End

JPX Nikkei 400 2021 Rebal Pre-Event L/S Basket +2.9% in April (thru the 28th). The 30th is rebal day for readers. 2 potential deletes and 7...

Share
bullish•SG Holdings
•23 Mar 2021 13:37

JPX-Nikkei 400 Rebalance: 2021 Preview

A presentation of a JPX Nikkei 400 Pre-Event Index Inclusion/Deletion trade. Historically it has been a good trade but this year is showing...

Share
bullish•Smartkarma
•02 Dec 2017 15:02

Smartkarma: ECM Coverage Weekly Update (2 December 2017)

The Smartkarma ECM Team puts out a weekly update on the deals we have covered recently, along with updates for upcoming IPOs. This week's activity...

Share
•01 Dec 2017 16:16

Sawai Pharm Placement - Dilution & Negative Sentiment Should Be Priced in After 18% Price Correction

Sawai Pharmaceutical Co Ltd (4555 JP) is looking to raise US$314m by selling 5m primary shares and 1m treasury shares (with 900,000...

Share
x